Consultant medical oncologist @ Imperial College Healthcare NHS Trust (Thoracic Oncology, Acute Oncology), Honorary Senior Clinical Lecturer @ Imperial College. Mum to Mr11. Perpetually tired!https://bsky.app/profile/oncolojo.bsky.socialhttps://bsky.app/profile/oncolojo.bsky.social/post/3lo5cttja6s2iSub-cut Nivolumab is go! https://www.gov.uk/government/news/mhra-authorises-cancer-treatment-variation-with-an-administration-time-of-3-5-minutes #LCSM @btog.bsky.social #Mesothelioma01 May 2025 22:03 +0000at://did:plc:5zpy5osgbtmvspv2ubpexc5k/app.bsky.feed.post/3lo5cttja6s2ihttps://bsky.app/profile/oncolojo.bsky.social/post/3lno6v535ms23@btog.bsky.social #Nostaligia25 Apr 2025 21:42 +0000at://did:plc:5zpy5osgbtmvspv2ubpexc5k/app.bsky.feed.post/3lno6v535ms23https://bsky.app/profile/oncolojo.bsky.social/post/3lmhc4satz22uFLAURA2 regimen now reimbursed. I have some questions. Who needs chemo? Everyone? Selected pts? Access to other therapies - assume Impower150 not available to patient who have had Chemo-Osi? Is chemo-Osi likely better than sequencing Osi-IMPOWER 150? Lung cancer keeps getting more complex!10 Apr 2025 10:26 +0000at://did:plc:5zpy5osgbtmvspv2ubpexc5k/app.bsky.feed.post/3lmhc4satz22uhttps://bsky.app/profile/oncolojo.bsky.social/post/3llhkmpj2pc26Mr11 has gone to #Nando’s to celebrate last day of term with his mates… means I get to eat stuff he won’t! Boom! Winner, winner salmon dinner!!28 Mar 2025 19:33 +0000at://did:plc:5zpy5osgbtmvspv2ubpexc5k/app.bsky.feed.post/3llhkmpj2pc26https://bsky.app/profile/oncolojo.bsky.social/post/3lkylqfsj6c2ePondering posting this since yesterday…. Yet another PIP report request asking when my patient with advanced lung cancer with brain mets might expect to be better from brain mets… is it appropriate to suggest they refer themself for brain imaging? 😡🤬😡🤬😡🤬🤬🤬22 Mar 2025 20:43 +0000at://did:plc:5zpy5osgbtmvspv2ubpexc5k/app.bsky.feed.post/3lkylqfsj6c2ehttps://bsky.app/profile/oncolojo.bsky.social/post/3lkeewefwws23@btog.bsky.social community, Assemble! [contains quote post or other embedded content]14 Mar 2025 19:48 +0000at://did:plc:5zpy5osgbtmvspv2ubpexc5k/app.bsky.feed.post/3lkeewefwws23https://bsky.app/profile/oncolojo.bsky.social/post/3ljxg6f3xjs2aOn the 5th Anniversary of Covid, I’m thinking of all those who lost their lives, including my cousin Julie Omar (Nee Harris), whose only error was going to work… https://www.bbc.co.uk/news/uk-england-hereford-worcester-5225589109 Mar 2025 16:06 +0000at://did:plc:5zpy5osgbtmvspv2ubpexc5k/app.bsky.feed.post/3ljxg6f3xjs2ahttps://bsky.app/profile/oncolojo.bsky.social/post/3ljmyu23a5c2y@annaminchom.bsky.social on newer small cell therapeutic strategies and management of CRS and ICANS as specific TRAEs With thought around timings of dose delivery and education of AOS teams and patients, safely deliverable within the NHS #BTOG2505 Mar 2025 12:41 +0000at://did:plc:5zpy5osgbtmvspv2ubpexc5k/app.bsky.feed.post/3ljmyu23a5c2yhttps://bsky.app/profile/oncolojo.bsky.social/post/3ljmy5rn4422uWith the successful role out of the TLHC programme, we now have a growing cohort of stage 1 SCLC patients. Hopefully this will become even more common, and work needed to understand optimal patient management @drjnaidoo.bsky.social #BTOG2505 Mar 2025 12:28 +0000at://did:plc:5zpy5osgbtmvspv2ubpexc5k/app.bsky.feed.post/3ljmy5rn4422uhttps://bsky.app/profile/oncolojo.bsky.social/post/3ljmxpj3cgk2uSmall cell in never smokers. On the rise for unknow reasons and a different biology. Having recently encountered my first patient who’s a never smoker(and no alcohol or recreational drugs), with extensive stage disease this insight is fascinating @stephenvliu.bsky.social #BTOG2505 Mar 2025 12:20 +0000at://did:plc:5zpy5osgbtmvspv2ubpexc5k/app.bsky.feed.post/3ljmxpj3cgk2uhttps://bsky.app/profile/oncolojo.bsky.social/post/3ljmxnj3ads2u@drjnaidoo.bsky.social on the limited stage small cell space and the excitement around CCRT-Durvalumab. EAMS currently open in England… #BTOG2505 Mar 2025 12:19 +0000at://did:plc:5zpy5osgbtmvspv2ubpexc5k/app.bsky.feed.post/3ljmxnj3ads2uhttps://bsky.app/profile/oncolojo.bsky.social/post/3ljmx2yqcq22u@stephenvliu.bsky.social on excitement in the Small Cell arena. PDL1/PD1 inhibition a practice changer, but so many potential game changers on the horizon from BITES To ADC, it’s exciting to see new drugs for an area of unmet need #BTOG2505 Mar 2025 12:09 +0000at://did:plc:5zpy5osgbtmvspv2ubpexc5k/app.bsky.feed.post/3ljmx2yqcq22uhttps://bsky.app/profile/oncolojo.bsky.social/post/3ljljhzesbs27@drsanjaypopat.bsky.social ! The OG!!! #BTOG25 @btog.bsky.social04 Mar 2025 22:33 +0000at://did:plc:5zpy5osgbtmvspv2ubpexc5k/app.bsky.feed.post/3ljljhzesbs27https://bsky.app/profile/oncolojo.bsky.social/post/3ljk7dzubq22yMagda Meissner on the Welsh ctDNA experience - an ‘in house’ solution assay wise and a huge amount of effort in validating and also learning to get more patients to test and more clinicians to genomic literacy #BTOG2504 Mar 2025 09:59 +0000at://did:plc:5zpy5osgbtmvspv2ubpexc5k/app.bsky.feed.post/3ljk7dzubq22yhttps://bsky.app/profile/oncolojo.bsky.social/post/3ljk6urnvpk2yDebra Montague on ensuring the patient voice is not lost. The most important person in the room after all! We haven’t lost the patient voice but we all need to be better at listening! #BTOG2504 Mar 2025 09:50 +0000at://did:plc:5zpy5osgbtmvspv2ubpexc5k/app.bsky.feed.post/3ljk6urnvpk2yhttps://bsky.app/profile/oncolojo.bsky.social/post/3ljk5tf7spc2nMatthew Krebs on ctDNA and moving away from confirmatory tissue testing where an informative result is present. Key number 1% VAF for determining of non-actionable mutations are informative #BTOG2504 Mar 2025 09:32 +0000at://did:plc:5zpy5osgbtmvspv2ubpexc5k/app.bsky.feed.post/3ljk5tf7spc2n